| Primary information |
|---|
| sequence ID | Seq_3265 |
| Peptide sequence | GTLSGIGTLDGFRHRHPDEAAF |
| CancerPDF_ID | CancerPDF_ID659, CancerPDF_ID10557, |
| PMID | 19795908,21805675 |
| Protein Name | Fibrinogen alpha chain,Fibrinogen alpha chain |
| UniprotKB Entry Name | FIBA_HUMAN,FIBA_HUMAN |
| Fluid | Plasma,Urine |
| M/Z | 785.39,2354.154 |
| Charge | 3,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,MALDI-TOF |
| Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF-MS |
| Quantification Technique | LC-MRM (multiple reaction monitoring),NA |
| Labelled/Label Free | Labelled,Label Free |
| FDR | less than 7%,1 |
| CancerPDF_ID | CancerPDF_ID659, CancerPDF_ID10557, |
| p-Value | NA,1.50E-26 |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,NA |
| Length | 22,22 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Muscle-invasive bladder cancer |
| Database | NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | "42 normal, 28patients",751 bladder cancer and 127 control |
| Regulation | NA,Upregulated in cancer vs normal |
| Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,0.768 |
| Peptide Atlas | NA |
| IEDB | |